funding-eu EU Horizon Europe HORIZON-MISS-2027-02 HORIZON-MISS-2027-02-CANCER-02 Anticancer therapy Clinical medicine Digital data

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

EU — Italia · scadenza 21/09/2027

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

Scadenza: 21/09/2027

Fonte: eu_funding_tenders

Tipo: EU

Pagina ufficiale: Apri la scheda sulla fonte ufficiale

Scheda (fonte ufficiale)

Topic metadata

EU Programme: Horizon Europe (ID 43108390)
Call identifier: HORIZON-MISS-2027-02
Call name: Supporting the implementation of the Cancer Mission
Type: Topic
Opening date: 10/02/2027
Next deadline: 21/09/2027
Keywords: HORIZON-MISS-2027-02-CANCER-02, HORIZON-MISS-2027-02, Anticancer therapy, Clinical medicine, Digital data, Gender in basic medicine, Personalised medicine, Radiology, nuclear medicine and medical imaging

Topic description

Expected Outcome:

Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:

Patients afflicted by lung, bowel, breast or prostate cancer^[1], will benefit from the outcomes of evidence-based, tailored, innovative, affordable and accessible diagnosis- and treatment-centred clinical research programmes by comprehensive cancer

Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.

Iscriviti ora